Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.


Peter Martin, M.D., Talks Trial of Oral Azacitidine Plus R-CHOP in High Risk DLBCL

Friday, January 5, 2018

Peter Martin, M.D., discusses a trial of the combination of oral azacitidine (CC-486) and R-CHOP in diffuse large B-cell lymphoma (DLBCL). This was a phase I, open-label, multicenter trial of oral azacitidine plus R-CHOP in patients with high-risk, previously untreated DLBCL, grade 3B follicular lymphoma, or transformed lymphoma.